Safety, tolerability, pharmacokinetics, and pharmacodynamics of HBM9161, a novel FcRn inhibitor, in a phase I study for healthy Chinese volunteers
Wellness Support, daily momentum, and recovery rhythm for a more intentional wellness routine
Recent studies suggested that mitochondrial DNA damage is also a potential biomarker in LRRK2-PD ( LRRK2 is an enzyme with both kinase and GTPase activities (Steger et al., 2016), which are important for exocytosis of synaptic vesicles, and endolysosomal and Golgi apparatus protein sorting (West et al., 2005
The Medicare GLP-1 Bridge Program is currently a temporary program scheduled to run from July 1, 2026 through December 31, 2027
Semaglutide is generally well-tolerated, making it a viable choice for many